Recombinant antibody against human insulin-like growth factor
View Patent ↗It is demanded that pharmaceutical agents for therapeutic treatment of diseases such as cancer, acromegaly and diabetic complications, of which IGF is involved in the progress of the conditions. The present invention provides a recombinant antibody or an antibody fragment thereof which specifically binds to human insulin-like growth factor-I (hereinafter referred to as hIGF-I) and human insulin-like growth factor-II (hereinafter referred to as hIGF-II) to inhibit the biological activities of human IGF-I and human IGF-II, a transformant producing the antibody or the antibody fragment thereof, a process for producing the antibody or the antibody fragment thereof, and a medicament comprising the antibody or the antibody fragment thereof as the active ingredient therein.
1. A recombinant antibody or an antibody fragment thereof, which specifically binds to human insulin-like growth factor-I (IGF-I) and human insulin-like growth factor-II (IGF-II) to inhibit control of proliferation, differentiation or apoptosis of epithelial cells of both human IGF-I and human IGF-II, wherein the VH of the recombinant antibody or the antibody fragment thereof comprises an amino acid sequence of SEQ ID NO:26 and the VL comprises an amino acid sequence of SEQ ID NO:27, 28 or 29.
2. The recombinant antibody or the antibody fragment thereof according to claim 1 , wherein the VL comprises an amino acid sequence of SEQ ID NO:27.
3. The recombinant antibody or the antibody fragment thereof according to claim 1 , wherein the VL comprises an amino acid sequence of SEQ ID NO:28.
4. The recombinant antibody or the antibody fragment thereof according to claim 1 , wherein the VL comprises an amino acid sequence of SEQ ID NO:29.
5. The recombinant antibody or the antibody fragment thereof according to any one of claims 1 or 2 - 4 , wherein the recombinant antibody is a human CDR-grafted antibody.
6. The recombinant antibody or the antibody fragment thereof according to any one of claims 1 or 2 - 4 , wherein the antibody fragment is an antibody fragment selected from the group consisting of Fab, Fab′, F(ab′) 2 , single-stranded antibody (scFv), dimerized variable region (diabody), disulfide-stabilized variable region (dsFv), and CDR-containing peptide.
7. The recombinant antibody or the antibody fragment thereof according to claim 5 , wherein the antibody fragment is an antibody fragment selected from the group consisting of Fab, Fab′, F(ab′) 2 , single-stranded antibody (scFv), dimerized variable region (diabody), disulfide-stabilized variable region (dsFv), and CDR-containing peptide.
8. A process for producing a recombinant antibody or the antibody fragment thereof according to any one of claims 1 , 2 - 4 , which comprises a step of culturing a transformant obtained by introducing into a host cell an expression vector carrying DNA encoding said recombinant antibody or antibody fragment thereof in a medium to produce the recombinant antibody or the antibody fragment thereof in a culture, and isolating and purifying the recombinant antibody or the antibody fragment thereof from the culture.
9. A process for producing a recombinant antibody or the antibody fragment thereof according to claim 5 , which comprises a step of culturing a transformant obtained by introducing into a host cell an expression vector carrying DNA encoding said recombinant antibody or antibody fragment thereof in a medium to produce the recombinant antibody or the antibody fragment thereof in a culture, and isolating and purifying the recombinant antibody or the antibody fragment thereof from the culture.
10. A process for producing a recombinant antibody or the antibody fragment thereof according to claim 6 , which comprises a step of culturing a transformant obtained by introducing into a host cell an expression vector carrying DNA encoding said recombinant antibody or antibody fragment thereof in a medium to produce the recombinant antibody or the antibody fragment thereof in a culture, and isolating and purifying the recombinant antibody or the antibody fragment thereof from the culture.
11. A process for producing a recombinant antibody or the antibody fragment thereof according to claim 7 , which comprises a step of culturing a transformant obtained by introducing into a host cell an expression vector carrying DNA encoding said recombinant antibody or antibody fragment thereof in a medium to produce the recombinant antibody or the antibody fragment thereof in a culture, and isolating and purifying the recombinant antibody or the antibody fragment thereof from the culture.